May 14, 2020 / 01:30PM GMT
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MD
Good morning, everybody. This is Bob Koort, I run the U.S. equity research effort here at Goldman Sachs on the chemical space. And from my team, I've also -- I've got Anthony Walker, who helps me cover Sherwin-Williams. From the Sherwin-Williams team, we've got John Morikis, Chairman and CEO; we've also got Jim Jaye, who's the Senior VP of IR and Corporate Communications; and Eric Swanson, who's VP of IR. Format, as with all our presentations today, Anthony and I will drill John and the team with questions. We've got a whole boat load lined up, but we'd prefer to ask client questions. So if you have any, on the web chat there, you've got a box where you can submit your question and we will filter those into the discussion. So with that, why don't we get started?
Questions and Answers:
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MDJohn, if you wouldn't mind, maybe from a high level, just talk about to begin what it is that Sherwin does that's so special or